150
Views
6
CrossRef citations to date
0
Altmetric
Review

Spotlight on once-monthly long-acting injectable aripiprazole and its potential as maintenance treatment for bipolar I disorder in adult patients

, &
Pages 285-292 | Published online: 11 Jan 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Eren Yıldızhan, Eda Uzun & Nesrin Buket Tomruk. (2022) Effect of long acting injectable antipsychotics on course and hospitalizations in bipolar disorder – a naturalistic mirror image study. Nordic Journal of Psychiatry 76:1, pages 37-43.
Read now

Articles from other publishers (4)

Darryl Bassett, Philip Boyce, Bill Lyndon, Roger Mulder, Gordon Parker, Richard Porter, Ajeet Singh, Erica Bell, Amber Hamilton, Grace Morris & Gin S. Malhi. (2022) Guidelines for the management of psychosis in the context of mood disorders. Schizophrenia Research 241, pages 187-196.
Crossref
Kanglai Li, Yingtao Liao, Zhihua Yang, Caishuang Yang, Minhua Chen, Xiuhua Wu & Zhaoyu Gan. (2021) Case Report: Paliperidone Palmitate in the Management of Bipolar I Disorder With Non-compliance. Frontiers in Psychiatry 11.
Crossref
Massimo Carlo Mauri, Alessandra Reggiori, Alessandro Minutillo, Gemma Franco, Chiara Di Pace, Silvia Paletta & Dario Cattaneo. (2020) Paliperidone LAI and Aripiprazole LAI Plasma Level Monitoring in the Prophylaxis of Bipolar Disorder Type I with Manic Predominance. Pharmacopsychiatry 53:05, pages 209-219.
Crossref
S. Dawood, J.G. Smith, N. Nadeem & C. Abbasian. (2020) Safety and effectiveness of long-acting injectable Aripiprazole in daily practice: A naturalistic retrospective study. The European Journal of Psychiatry 34:2, pages 82-89.
Crossref